Brief: Fluicell Initiates In Vivo Studies In Diabetes Treatment

Fluicell AB

21/12/2023 12:12

Dec 21 (Reuters) - Fluicell AB  FLUIC.ST :
    * FLUICELL INITIATES IN VIVO STUDIES IN TISSUE-BASED TYPE 1
DIABETES TREATMENT PROGRAM

Source text for Eikon:  ID:nWkr8fMG6V 
Further company coverage:  FLUIC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))